Literature DB >> 15698577

Regulation of CYP3A genes in the human respiratory tract.

Hannu Raunio1, Jukka Hakkola, Olavi Pelkonen.   

Abstract

The CYP3A gene cluster consists of four members, CYP3A4, CYP3A5, CYP3A7 and CYP3A43. Especially the CYP3A4 and CYP3A5 enzymes play a significant role in the metabolism of numerous exogenous (drugs, pollutants, procarcinogens) and endogenous (steroids, bile acids) compounds. CYP3A5 protein is present in the liver and some extrahepatic tissues, such as the gut wall, kidney, adrenal gland, prostate and many cell types in the lung. In the lung, the highest amounts of CYP3A5 protein are present in bronchial and alveolar epithelial cells, bronchial glands and alveolar macrophages. The same cells types have little or no CYP3A4 expression. Cigarette smoking markedly represses CYP3A5 content in alveolar macrophages. CYP3A5 is upregulated by glucocorticoids via the glucocorticoid receptor (GR) in lung adenocarcinoma derived A549 cells. Tissue selective distribution of CYP3A4 is controlled by tissue enriched transcription factors, such as hepatic nuclear factor 4alpha (HNF4alpha), and ligand dependent nuclear receptors, most notably pregnane X receptor (PXR) and constitutive androstane receptor (CAR). The selective expression of CYP3A5 over CYP3A4 in specific lung cells is likely to be the sum of the effects of tissue-specific upregulating and downregulating transcription factors in these cells. Since the CYP3A4/5 enzymes mediate the metabolism of many exogenous and endogenous compounds with direct relevance to pulmonary physiology and pathology, the functions of these enzymes and factors controlling them should be elucidated in much more detail.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15698577     DOI: 10.1016/j.cbi.2003.12.007

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  7 in total

1.  Use of human bronchial epithelial cells (BEAS-2B) to study immunological markers resulting from exposure to PM(2.5) organic extract from Puerto Rico.

Authors:  Enrique Fuentes-Mattei; Evasomary Rivera; Adriana Gioda; Diana Sanchez-Rivera; Felix R Roman-Velazquez; Braulio D Jimenez-Velez
Journal:  Toxicol Appl Pharmacol       Date:  2009-12-21       Impact factor: 4.219

2.  Evidence-based prevention (EBP): A review of cytochrome P450 expression in the bronchial epithelium and new approach to lung cancer prevention.

Authors:  Tsunehiro Oyama; Toyohi Isse; Tomoe Murakami; Rie Suzuki-Narai; Masanori Ogawa; Tetsunosuke Yamaguchi; Tsuyoshi Kinaga; Yasunori Yashima; Shinichi Ozaki; Yong-Dae Kim; Heon Kim; Toshihiro Kawamoto
Journal:  Environ Health Prev Med       Date:  2006-05       Impact factor: 3.674

3.  Low free drug concentration prevents inhibition of F508del CFTR functional expression by the potentiator VX-770 (ivacaftor).

Authors:  Elizabeth Matthes; Julie Goepp; Graeme W Carlile; Yishan Luo; Kurt Dejgaard; Arnaud Billet; Renaud Robert; David Y Thomas; John W Hanrahan
Journal:  Br J Pharmacol       Date:  2016-01-13       Impact factor: 8.739

4.  Functional polymorphisms in CYP2C19 & CYP3A5 genes associated with decreased susceptibility for paediatric tuberculosis.

Authors:  Wei-Xing Feng; Fang Liu; Yi Gu; Wei-Wei Jiao; Lin Sun; Jing Xiao; Xi-Rong Wu; Qing Miao; Chen Shen; Dan Shen; Adong Shen
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

Review 5.  Role of nuclear receptor PXR in immune cells and inflammatory diseases.

Authors:  Le Sun; Zhenzhen Sun; Qian Wang; Yue Zhang; Zhanjun Jia
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

6.  Regulation of CYP3A genes by glucocorticoids in human lung cells.

Authors:  Jessica K Roberts; Chad D Moore; Erin G Romero; Robert M Ward; Garold S Yost; Christopher A Reilly
Journal:  F1000Res       Date:  2013-08-13

Review 7.  Role of vitamin D receptor in the regulation of CYP3A gene expression.

Authors:  Xuan Qin; Xin Wang
Journal:  Acta Pharm Sin B       Date:  2019-04-04       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.